Pharmacokinetic and Pharmacodynamic Implications of P-Glycoprotein Modulation
Modulation of P-glycoprotein (Pgp)-mediated transport has significant pharmacokinetic implications for Pgp substrates. Pharmacokinetic alterations may be at the systemic (blood concentrations), regional (organ or tissue concentrations), or local (intracellular concentrations) level. Regardless of the particular location of Pgp modulation, changes in substrate pharmacokinetics will have the potential to alter the magnitude and duration of pharmacologic effect (pharmacodynamics). It is important to understand each of the aspects of Pgp modulation for a given Pgp substrate in order to predict the degree to which Pgp modulation may affect that substrate, to minimize untoward effects associated with that modulation, or to exploit that modulation for specific therapeutic advantage.
- Calibration of Microarray Gene-Expression Data
- Mutation Detection in Colorectal Cancers: Direct Sequencing of DNA Mismatch Repair Genes
- Adenovirus-Mediated Targeted Gene Therapy for Breast Cancer and for Purging Hematopoietic Stem-Cell Sources
- Cell Cycle Checkpoint Control Mechanisms That Can Be Disrupted in Cancer
- Laser-Capture Microdissection
- Co-immunoprecipitation of Tumor Suppressor Protein-Interacting Proteins
- Diagnostic Markers in Hepatocellular Carcinoma Using Immunohistochemical Techniques
- Advances in Adjuvant Therapy: Potential for Prognostic and Predictive Biomarkers
- 跨越世纪的生命赞歌(第三部分)
- Detection of ras Gene Mutations Using Oligonucleotide Ligation Technology